Skip to content

The Effect of Probiotic and Zinc Supplementation on the Common Cold

The Effect of Probiotic and Zinc Supplementation on the Common Cold in Healthy Adults

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04672850
Enrollment
100
Registered
2020-12-17
Start date
2021-01-27
Completion date
2022-11-30
Last updated
2022-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold

Brief summary

The purpose with this study is to investigate the preventative effect of a supplement containing a combination of probiotic bacteria and fungi as well as zinc on the common cold. The hypothesis is that it will shorten the duration, alleviate the severity of symptoms or even decrease the number of infectons during the intervention period. This study is a randomzed placebo controlled human study were healthy adults will consume the supplement for three months.

Interventions

DIETARY_SUPPLEMENTProbiotic

The participants will consume 2 capsules daily for three months

DIETARY_SUPPLEMENTPlacebo

The participants will consume 2 capsules daily for three months

Sponsors

Coradil AB
CollaboratorUNKNOWN
Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Double-blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults

Exclusion criteria

* Diagnosed gastrointestinal disorders * Autoimmune diseases or immuno compromized * Antibiotic treatment in the last month

Design outcomes

Primary

MeasureTime frameDescription
Symptoms severityThree monthsDecrease in the severity of symptoms will be determined using a common cold questionnaire.

Secondary

MeasureTime frameDescription
Composition of gut and oral microbiomeThree monthsChange in gut and oral microbiome will be measured using 16SrRNA and 18SrRNA sequencing
IgAThree monthsChanges in levels of IgA in saliva and/or feces will be measured using ELISA
Duration of symptomsThree monthsDecrease in duration of cold will be determined using a common cold questionnaire
Number of coldsThree monthsDecrease in number of colds will be determined using a common cold questionnaire

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026